journal article·2025-12Open access

Sustained suppression of choroidal neovascularization by intraocularly stable tetrahedral network encapsulated miR-22–3p

Xinyu Liu, You Wang, Junyang Huang, Li Chen, Tao Cai, Qiong Wang, Shiqi Li, Guoqiang Yu, Yue Chen, Delun Luo, Xiaoyan Ding

Abstract

Choroidal neovascularization (CNV), characterized by abnormal vessel growth and vascular leakage, is the hallmark of wet age-related macular degeneration (wAMD) and a leading cause of irreversible vision loss. Although anti-vascular endothelial growth factor (VEGF) therapies remain the current standard, their frequent administration and limited long-term efficacy highlight the need for novel treatments. Here, we developed a miR-22-3p-loaded tetrahedral framework nucleic acids (tFNAs-miR22) nanostructure and evaluated its efficacy in CNV suppression. The nanocomplex was structurally validated, exhibiting high assembly fidelity and superior intraocular stability compared to serum conditions. In a laser-induced CNV mouse model, a single intravitreal injection of tFNAs-miR22 significantly reduced lesion size and leakage by day 10, with efficacy comparable to aflibercept. In a rat model of stable and long-lasting CNV, tFNAs-miR22 demonstrated durable inhibition of vascular leakage by Day 21, showing greater persistence compared to aflibercept. This effect was dose-dependent, with the high-dose group outperforming aflibercept in suppressing leakage. Transcriptomic profiling of hypoxia-challenged HUVECs further revealed that tFNAs-miR22 modulates angiogenic pathways, including suppression of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) axis. These findings demonstrate the potent and long-lasting therapeutic effects of tFNAs-miR22, supporting its promise as a next-generation, gene-regulatory nanotherapy for sustained inhibition of CNV.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Retinal Diseases and Treatments · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Age-related macular degeneration10.1258/jrsm.2009.080298 ↗
2. Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 205010.1186/s12889-024-21047-x ↗
3. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis10.1016/S2214-109X(13)70145-1 ↗
4. Neovascular age-related macular degeneration10.1159/000438969 ↗
5. Photoreceptor loss in age-related macular degeneration
6. Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives10.1007/s00441-021-03514-8 ↗
7. Ranibizumab versus verteporfin for neovascular age-related macular degeneration10.1056/NEJMoa062655 ↗
8. Treatment burden in neovascular AMD:Visual acuity outcomes are associated with Anti-VEGF injection frequency10.3928/23258160-20170928-01 ↗
9. Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities10.1016/j.preteyeres.2020.100906 ↗
10. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials10.1016/j.ophtha.2013.08.015 ↗
11. Intravitreal ranibizumab May induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration10.1016/j.ophtha.2009.03.017 ↗
12. MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration
13. Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis10.1016/j.omtn.2021.10.003 ↗
14. miR-22-3p suppresses endothelial progenitor cell proliferation and migration via inhibiting onecut 1 (OC1)/Vascular endothelial growth factor A (VEGFA) signaling pathway and its clinical significance in venous thrombosis10.12659/MSM.925482 ↗
15. MiR-22-3p suppresses vascular remodeling and oxidative stress by targeting CHD9 during the development of hypertension10.1159/000514311 ↗
16. MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus10.1186/s12974-022-02548-1 ↗
17. Trials and tribulations of MicroRNA therapeutics10.3390/ijms25031469 ↗
18. The application of tetrahedral framework nucleic acids as a drug carrier in biomedicine fields10.2174/1574888X15666200422103415 ↗
19. Systematic study in mammalian cells showing no adverse response to tetrahedral DNA nanostructure10.1021/acsami.8b02626 ↗
20. Progress in biomedical applications of tetrahedral framework nucleic acid-based functional systems10.1021/acsami.0c13806 ↗
21. Anti-inflammatory and antioxidative effects of tetrahedral DNA nanostructures via the modulation of macrophage responses10.1021/acsami.7b17928 ↗
22. Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischaemic retinopathy via PI3K/AKT/mTOR signalling pathway10.1111/cpr.13407 ↗
23. Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway10.1039/C9NR07171G ↗
24. Tetrahedral framework nucleic acids promote corneal epithelial wound healing in vitro and in vivo
25. Ocular drug delivery to the retina: current innovations and future perspectives10.3390/pharmaceutics13010108 ↗
26. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice10.1038/nprot.2013.135 ↗
27. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor
28. Hydrogen peroxide-induced oxidative damage and protective role of peroxiredoxin 6 protein via EGFR/ERK signaling pathway in RPE cells10.3389/fnagi.2023.1169211 ↗
29. Age-related macular degeneration: role of oxidative stress and blood vessels10.3390/ijms22031296 ↗
30. The current progress of tetrahedral DNA nanostructure for antibacterial application and bone tissue regeneration10.2147/IJN.S403882 ↗
31. DNA tetrahedra-based delivery of MicroRNA-22 to reduce depressive symptoms in mice10.1021/acsami.3c03054 ↗
32. Fluorescence coupled capillary electrophoresis as a strategy for tetrahedron DNA analysis10.1016/j.talanta.2021.122225 ↗
33. The single-step synthesis of a DNA tetrahedron10.1039/b402293a ↗
34. Purification of self-assembled DNA tetrahedra using gel electrophoresis10.1002/cpz1.560 ↗
35. Loop-armed DNA tetrahedron nanoparticles for delivering antisense oligos into bacteria10.1186/s12951-020-00667-6 ↗
36. Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1)
37. A replicable tetrahedral nanostructure self-assembled from a single DNA strand10.1021/ja903768f ↗
38. Treatment efficacy of a dual release of aflibercept and dexamethasone from a single hydrogel drug delivery system in a rodent model10.1167/tvst.14.6.31 ↗
39. Role of akt signaling in vascular homeostasis and angiogenesis10.1161/01.RES.0000022200.71892.9F ↗